Avanos Medical Inc (NYSE: AVNS) stock suffered a major decline of -17.2% on 1/4/24. The shares closed at $17.97. Moreover, this decline was accompanied by exceptionally high trading volume at 233% of normal. The stock has declined -21.3% during the last week and has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be in line with the cost of capital, AVNS is expected to be Value Creation neutral.
Avanos Medical has a current Value Trend Rating of C (Low Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing contradictory signals. Avanos Medical has a slightly positive Appreciation Score of 70 but a poor Power Rating of 21, with the Low Neutral Value Trend Rating the result.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment